What You'll Need to Launch a Business...
Inauguration Day Will Be a Big Turning Point in the Stock Market
Why We Really Need to Start Rethinking the Economy
Chinese Currency Manipulation Could Become A Global Problem in 2017
Why Investors Shouldn't Forget About P2P Lending in 2017
NanoViricides, Inc.'s (NNVC) Dr. Eugene Seymour sits down with Equities.com and talks about their role in the discovery and development of therapeutics for the treatment of viral infections.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).